Home » Topics » Cardiovascular and Metabolic Disorders »
Lipids and Cholesterol
Bempedoic acid was found to be safe and effective at lowering LDL-C in patients with hypercholesterolemia.
In US veterans aged 75 years and older, statin use is associated with reduced all-cause and cardiovascular mortality.
An algorithm using simple clinical variables was proposed for the diagnosis of dysbetalipoproteinemia.
Suboptimal adherence to and low prescribing of high-intensity statin therapy may be associated with the modest reductions in LDL-C observed in patients with ASCVD.
Low mean levels and high variability of HDL-C were found to be associated with increased risks for stroke, myocardial infarction and all-cause mortality.
The use of statins appears to benefit patients hospitalized with COVID-19, according to the findings of a retrospective study conducted in Hubei Province, China.
Up-titration to high-intensity statins early on in the course of treatment was found to be associated with a lower risk for cardiovascular (CV) events compared with no up-titration in patients at very high risk for CV disease.
Elevated lipoprotein(a) levels was not found to be caused by FH, but may help with clinical recognition of genetic FH.
Metabolic traits associated with adult diabetes risk may be detectable by age 8 years.
Revisional bariatric surgery in patients with persistent metabolic disease may improve obesity-related comorbidities and metabolic outcomes.
The risk for peripheral artery disease events was found to be associated with levels of lipoprotein(a) in patients with recent acute coronary syndrome.
Want to read more?
Please login or register first to view this content.